Table 1.

HPV status in 2850 cervical cancer cases from a nationwide audit procedure, listed by type (single infections only), multiple, negative respectively, as defined by Luminex and/or RT-PCR results

		% of valid	% of single positive
HPV type	No. of cases (n)	% (95% CI)	% (95% CI)
16	1401	49.2 (47.3–51.0)	57.04 (55.1–59.0)
18	459	16.1 (14.8–17.5)	18.69 (17.2–20.9)
45	175	6.1 (5.3–7.1)	7.1 (6.1–8.2)
31	68	2.4 (1.9–3.0)	2.77 (2.2–0.3)
33	46	1.6 (1.2–2.1)	1.87 (1.4–2.5)
52	39	1.4 (1.0–1.9)	1.59 (1.1–2.2)
39	22	0.8 (0.5–1.2)	0.90 (0.6–1.4)
70	22	0.8 (0.5–1.2)	0.90 (0.6–1.4)
56	21	0.7 (0.5–1.1)	0.86 (0.5–1.3)
35	20	0.7 (0.4–1.1)	0.81 (0.5–1.3)
58	18	0.6 (0.4–1.0)	0.73 (0.4–1.2)
59	14	0.5 (0.3–0.8)	0.57 (0.3–1.0)
6	11	0.4 (0.2–0.7)	0.45 (0.2–0.8)
66	8	0.3 (0.1–0.6)	0.33 (0.1–0.6)
53	7	0.2 (0.1–0.5)	0.29 (0.1–0.6)
42	6	0.2 (0.08–0.5)	0.24 (0.09–0.5)
11	5	0.2 (0.06–0.4)	0.20 (0.07–0.5)
67	5	0.2 (0.06–0.4)	0.20 (0.07–0.5)
68	5	0.2 (0.06–0.4)	0.20 (0.07–0.5)
51	4	0.1 (0.04–0.4)	0.16 (0.04–0.4)
73	4	0.1 (0.04–0.4)	0.16 (0.04–0.4)
90	2	0.07 (0.008–0.3)	0.08 (0.01–0.3)
69	1	0.04 (0.001–0.2)	0.04 (0.001–0.2)
87	1	0.04 (0.001–0.2)	0.04 (0.001–0.2)
Multiple	92	3.23 (2.6–3.9)	3.75 (3.0–4.6)
Negative	394	NA	NA
Total	2850	86.2 (84.9–87.4)	100%